Skip to main content
Fig. 9 | BMC Public Health

Fig. 9

From: Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland

Fig. 9

Posterior odds ratio for the chemotherapy-specific spatial effect at SLA level, 1997–2008. Estimated posterior odds ratio for the 478 SLA chemotherapy-specific spatial effect among all study cohort across QLD. Map (a) with median value of the chemotherapy-specific spatial effect separated into quintiles (<0.77, 0.91, 1.10, 1.30, 1.30 +) and a line plot (b) for the ranked SLA median chemotherapy-specific spatial effect values with 95 % credible interval

Back to article page